Switching from CD20 inhibitors to fumarate therapies reduces healthcare visits and infection-related costs, while controlling ...
A low educational status was associated with longer delays before initiating treatment among relapsing-remitting MS patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback